查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1603754

到 2030 年水微生物检测市场预测：按产品类型、病原体类型、水类型、最终用户和地区进行的全球分析

Microbiological Testing of Water Market Forecasts to 2030 - Global Analysis By Product Type, Pathogen Type, Water Type, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球水微生物检测市场规模为 19.6 亿美元，预计在预测期内将以 9.4% 的复合年增长率增长，到 2030 年达到 33.6 亿美元。

水的微生物检测是评估水质并确保人类饮用、工业使用和环境保护安全的重要过程。此测试可识别和测量可能引起水传播感染疾病并造成严重健康风险的微生物，例如细菌、病毒和原生动物。大肠桿菌和大肠桿菌等重要标记物经常被追踪，因为它们可以表明粪便或其他危险源的污染。此外，微生物水测试在需要严格品质标准的环境中至关重要，例如市政供水系统和食品和饮料製造。

根据美国环保署 (EPA) 的规定，《安全饮用水法案》要求公共供水系统含有大肠桿菌群，以保护依赖公共饮用水系统的 3 亿多美国人，并要求定期进行微生物检测。 ：

增加有关水传播感染疾病的知识

随着水传播感染疾病在全球的流行，人们对水质重要性的认知不断增强。特别是霍乱、伤寒和甲型肝炎等疾病可能对弱势族群的健康造成毁灭性影响。随着社区越来越意识到这些风险，对微生物检测以确保饮用水安全且不含病原体的需求正在增加。此外，这种认知的提升也是旨在预防疾病爆发的健康措施和教育宣传活动的结果。

测试成本高

检测方法和检测设备成本高昂是水微生物检测市场的主要障碍之一。这些需要大量的初始投资，但流式细胞技术和聚合酵素链锁反应(PCR) 等先进技术可提高速度和准确性。小型企业和组织，尤其是开发中国家的小型企业和组织，可能会发现很难负担这些昂贵的测试解决方案。这可能会限制市场进入并降低采用率。此外，复杂检测设备的持续维护和校准可以减少微生物检测设施的投资并进一步增加营运成本。

即时监控解决方案需求

人们对水安全意识的增强以及对污染事件快速反应机制的需求正在推动对即时监控解决方案的需求。正在开发基于人工智慧的分析和自动测试设备等技术，以提高资料准确性并加快测试过程。例如，为了提高吞吐量并减少错误，自动化系统可以在几乎不需要人工帮助的情况下收集和分析水样本。此外，除了改善公共健康和安全之外，即时监测还符合及时报告水质问题的法律义务。

改变微生物的特性

微生物不断变化的性质是微生物检测市场的最大威胁之一。由于病原体不断变化和适应，可能会出现使用目前检测方法难以识别的新菌株。这需要不断调整和改进测试方法，这需要实验室和测试设施的成本和资源。此外，如果不适应这些变化，可能会导致未被发现的污染，使公众健康面临风险，并削弱人们对检测结果的信心。

COVID-19 的影响：

COVID-19 对水微生物检测市场产生了复杂的影响，既带来了机会，也带来了挑战。最初，疫情扰乱了实验室和供应链的业务，导致检测服务延迟和水质评估积压。然而，大流行引起的对健康和安全的日益关注，急剧增加了公众对水质的担忧，导致对微生物检测以确保饮用水安全的需求增加。为了应对疫情，监管机构也加强了对水质标准的审查，这推动了市场。

预计大肠菌群在预测期内将达到最大值

预计水微生物检测市场将占据大肠桿菌群的最大份额。大肠桿菌群测试对于确保安全饮用水至关重要，因为它经常被用作水质和可能污染的指标。许多测试是在公共和私人自来水中进行的，因为如果存在大肠桿菌，则也可能存在其他危险的病原体。此外，随着公众对水传播感染疾病的认识提高和法律规范收紧，大肠桿菌预计将继续保持其市场主导，这凸显了微生物在水质评估中的重要作用。

预计製药和生物技术产业在预测期内复合年增长率最高

製药和生物技术产业预计将以最高的复合年增长率成长。药品生产过程中对水质的严格监管要求是这一增长的关键驱动力，其中纯度和污染控制至关重要。由于微生物污染可能威胁患者安全和产品完整性，因此製药业主要依靠微生物检测来确保药品生产中使用的水符合安全标准。此外，人们对生物製药和个人化医疗的兴趣日益浓厚，因此更加重视品管措施，例如对製造和研究中使用的水进行严格的测试程序。

占比最大的地区：

由于基础设施完善以及有关水安全和品质的严格法规，北美地区在水微生物检测市场中占据最大份额。包括市政供水、食品和饮料以及药品在内的各个领域对遵守微生物检测的强烈需求反映了在这个新兴市场确保安全饮用水的重要性。此外，该地区的优势还在于其高度发展的技术力。因为企业不断投资尖端检测技术以提高效率和准确性。

复合年增长率最高的地区：

水微生物检测市场预计将以欧洲地区最高的复合年增长率成长。这是由于各行业对微生物检测设备和套件的需求不断增加，特别是在食品和饮料、製药和工业加工领域。由于欧洲药品管理局 (EMA) 对药品生产中的水质製定了严格的合规要求，因此可靠的测试解决方案比以往任何时候都更加重要。此外，欧盟改善清洁饮用水供应和提高公众水安全意识的措施正在推动市场扩张。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球水微生物检测市场：依产品类型

  • 检测套组
    • 微生物检测套组
    • 三磷酸Adenosine（ATP）检测套组
  • 过滤器和薄膜
    • 薄膜过滤
    • 超过滤
  • 装置
  • 其他产品类型

第六章全球水微生物检测市场：依病原体类型

  • 大肠桿菌
  • 弧菌
  • 退伍军人菌
  • 梭状芽孢桿菌
  • 沙门氏菌
  • 其他病原体类型

第七章全球水微生物检测市场：依水类型

  • 饮用水和瓶装水
  • 工业用水

第八章全球水微生物检测市场：依最终用户分类

  • 食品和饮料 (F&B) 行业
  • 製药和生物技术
  • 医院和医疗保健
  • 工业製程
  • 环境
  • 化学品和材料
  • 其他最终用户

第九章全球水微生物检测市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • 3M Company
  • Agilent Technologies, Inc
  • Charles River Laboratories, Inc.
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Avantor Inc.
  • Merck KGaA
  • Shimadzu Corporation
  • LaMotte Company
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • Perkinelmer, Inc
  • Accepta Ltd
  • Dohler Group
  • Eurofins Scientific SE
Product Code: SMRC27773

According to Stratistics MRC, the Global Microbiological Testing of Water Market is accounted for $1.96 billion in 2024 and is expected to reach $3.36 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Microbiological testing of water is a critical process used to assess water quality and ensure it is safe for human consumption, industrial use, and environmental protection. This testing entails identifying and measuring microorganisms that can cause waterborne illnesses and present significant health risks, including bacteria, viruses, and protozoa. Important markers, such as coliform bacteria and Escherichia coli (E. coli), are frequently tracked because they may indicate contamination from feces or other dangerous sources. Moreover, microbiological water testing is crucial in environments where strict quality standards are required, such as municipal water systems and food and beverage production.

According to the Environmental Protection Agency (EPA), the Safe Drinking Water Act mandates that public water systems perform regular microbiological testing for contaminants such as coliform bacteria, as part of efforts to protect over 300 million Americans who rely on public drinking water systems.

Market Dynamics:

Driver:

Increasing knowledge of waterborne illnesses

Public awareness of the significance of water quality has increased as a result of the rising prevalence of waterborne illnesses worldwide. Particularly in susceptible groups, diseases like cholera, typhoid fever, and hepatitis A can have catastrophic health consequences. The need for microbiological testing to guarantee that drinking water is safe and pathogen-free is growing as communities become more aware of these dangers. Additionally, this increased awareness is also a result of health initiatives and educational campaigns that try to prevent disease outbreaks.

Restraint:

High testing costs

The high expense of testing methods and equipment is one of the main barriers to the market for microbiological testing of water. Although they require a large initial investment, advanced technologies like flow cytometry and polymerase chain reaction (PCR) provide increased speed and accuracy. Smaller businesses and organizations might find it difficult to pay for these pricey testing solutions, especially in developing nations. As a result, market participation may be restricted and adoption rates may be slower. Furthermore, investment in microbiological testing facilities may be discouraged by the continued maintenance and calibration of complex testing apparatus, which raises operating costs even more.

Opportunity:

Demand for monitoring solutions in real time

Growing water safety awareness and the need for rapid response mechanisms to contamination events have led to an increase in demand for real-time monitoring solutions. Technologies are being developed to improve data accuracy and expedite the testing process, including AI-driven analytics and automated testing devices. To increase throughput and decrease errors, automated systems, for example, can gather and analyze water samples with little assistance from humans. Moreover, besides improving public health and safety, this move to real-time monitoring also complies with legal mandates for prompt reporting of water quality problems.

Threat:

Changing character of microorganisms

The constantly changing nature of microorganisms is one of the biggest threats to the market for microbiological testing. Because pathogens are always changing and adapting, new strains may appear that are difficult for current testing methods to identify. This calls for constant testing method adaptation and improvement, which can be expensive and resource-intensive for labs and testing facilities. Additionally, failure to adapt to these changes may lead to contamination that goes unnoticed, endangering public health and eroding trust in test results.

Covid-19 Impact:

COVID-19 has had a complex effect on the market for microbiological testing of water, posing both opportunities and challenges. Initially, the pandemic disrupted laboratory and supply chain operations, leading to delays in testing services and a backlog of water quality assessments. However, the pandemic's increased focus on health and safety led to a sharp rise in public anxiety about water quality, which in turn fuelled demand for microbiological testing as people looked for guarantees regarding the safety of their drinking water. In reaction to the pandemic, regulatory agencies also increased their scrutiny of water quality standards, which helped to drive the market.

The Coliform segment is expected to be the largest during the forecast period

The market for microbiological testing of water is expected to be the largest share in the coliform segment. Testing for coliform bacteria is essential to guaranteeing safe drinking water because they are frequently used as an indicator of water quality and possible contamination. Numerous tests are conducted on both public and private water supplies because the presence of coliforms raises the possibility of the presence of other dangerous pathogens. Moreover, the coliform segment is anticipated to continue to hold its market leadership as public awareness of waterborne illnesses rises and regulatory frameworks become stricter, highlighting its critical role in microbial water quality assessment.

The Pharmaceutical and Biotechnology segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotechnology segment is anticipated to grow at the highest CAGR. The strict regulatory requirements for water quality in pharmaceutical manufacturing processes, where purity and contamination control are crucial, are the main driver of this growth. Since any microbial contamination can jeopardize patient safety and product integrity, the pharmaceutical industry mainly depends on microbiological testing to make sure that water used in drug production satisfies safety standards. Additionally, a stronger emphasis on quality control measures, such as stringent testing procedures for water used in production and research, has also resulted from the growing interest in biopharmaceuticals and personalized medicine.

Region with largest share:

Due to its established infrastructure and strict regulations pertaining to water safety and quality, the North American region commands the largest share of the market for microbiological testing of water. Strong compliance requirements for microbiological testing across a range of sectors, including municipal water supplies, food and beverage, and pharmaceuticals, reflect the importance of ensuring safe drinking water in this developed market. Furthermore, the region's dominance is also a result of its highly developed technological capabilities, as businesses consistently invest in cutting-edge testing techniques to improve efficiency and accuracy.

Region with highest CAGR:

The market for microbiological testing of water is expected to grow at the highest CAGR in the Europe region due to the growing need for microbiological testing equipment and kits in a variety of industries, especially in the food and beverage, pharmaceutical, and industrial processes sectors. Reliable testing solutions are more important than ever because of the European Medicines Agency's (EMA) stringent compliance requirements for water quality in pharmaceutical production. Moreover, the EU's efforts to increase access to clean drinking water and increased public awareness of water safety are driving market expansion.

Key players in the market

Some of the key players in Microbiological Testing of Water market include 3M Company, Agilent Technologies, Inc, Charles River Laboratories, Inc., IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Avantor Inc., Merck KGaA, Shimadzu Corporation, LaMotte Company, Danaher Corporation, Bio-Rad Laboratories Inc., Perkinelmer, Inc, Accepta Ltd, Dohler Group and Eurofins Scientific SE.

Key Developments:

In August 2024, Avantor has announced a definitive agreement to divest its clinical services business to Audax Private Equity for approximately $650 million. This strategic move aims to optimize Avantor's portfolio and sharpen its focus on lab and production businesses. The transaction, expected to close in Q4 2024, will generate about $475 million in after-tax cash proceeds, which will be used for debt paydown.

In July 2024, Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million. Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.

In February 2023, Thermo Fisher Scientific Inc. entered into a definitive agreement to acquire CorEvitas, a provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity, for $912.5 million in cash. CorEvitas will become part of Thermo Fisher's Laboratory Products and Biopharma Services segment. The transaction is expected to be completed by the end of 2023.

Product Types Covered:

  • Testing Kits
  • Filters and Membranes
  • Instruments
  • Other Product Types

Pathogen Types Covered:

  • Coliform
  • Vibrio
  • Legionella
  • Clostridium
  • Salmonella
  • Other Pathogen Types

Water Types Covered:

  • Drinking and Bottled Water
  • Industrial Water

End Users Covered:

  • Food & Beverage (F&B) Industry
  • Pharmaceutical and Biotechnology
  • Hospitals and Healthcare
  • Industrial Process
  • Environmental
  • Chemicals and Materials
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbiological Testing of Water Market, By Product Type

  • 5.1 Introduction
  • 5.2 Testing Kits
    • 5.2.1 Microbiological Test Kits
    • 5.2.2 Adenosine Triphosphate (ATP) Testing Kits
  • 5.3 Filters and Membranes
    • 5.3.1 Membrane Filtration
    • 5.3.2 Ultrafiltration
  • 5.4 Instruments
  • 5.5 Other Product Types

6 Global Microbiological Testing of Water Market, By Pathogen Type

  • 6.1 Introduction
  • 6.2 Coliform
  • 6.3 Vibrio
  • 6.4 Legionella
  • 6.5 Clostridium
  • 6.6 Salmonella
  • 6.7 Other Pathogen Types

7 Global Microbiological Testing of Water Market, By Water Type

  • 7.1 Introduction
  • 7.2 Drinking and Bottled Water
  • 7.3 Industrial Water

8 Global Microbiological Testing of Water Market, By End User

  • 8.1 Introduction
  • 8.2 Food & Beverage (F&B) Industry
  • 8.3 Pharmaceutical and Biotechnology
  • 8.4 Hospitals and Healthcare
  • 8.5 Industrial Process
  • 8.6 Environmental
  • 8.7 Chemicals and Materials
  • 8.8 Other End Users

9 Global Microbiological Testing of Water Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 3M Company
  • 11.2 Agilent Technologies, Inc
  • 11.3 Charles River Laboratories, Inc.
  • 11.4 IDEXX Laboratories, Inc.
  • 11.5 Thermo Fisher Scientific, Inc.
  • 11.6 Avantor Inc.
  • 11.7 Merck KGaA
  • 11.8 Shimadzu Corporation
  • 11.9 LaMotte Company
  • 11.10 Danaher Corporation
  • 11.11 Bio-Rad Laboratories Inc.
  • 11.12 Perkinelmer, Inc
  • 11.13 Accepta Ltd
  • 11.14 Dohler Group
  • 11.15 Eurofins Scientific SE

List of Tables

  • Table 1 Global Microbiological Testing of Water Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Microbiological Testing of Water Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Microbiological Testing of Water Market Outlook, By Testing Kits (2022-2030) ($MN)
  • Table 4 Global Microbiological Testing of Water Market Outlook, By Microbiological Test Kits (2022-2030) ($MN)
  • Table 5 Global Microbiological Testing of Water Market Outlook, By Adenosine Triphosphate (ATP) Testing Kits (2022-2030) ($MN)
  • Table 6 Global Microbiological Testing of Water Market Outlook, By Filters and Membranes (2022-2030) ($MN)
  • Table 7 Global Microbiological Testing of Water Market Outlook, By Membrane Filtration (2022-2030) ($MN)
  • Table 8 Global Microbiological Testing of Water Market Outlook, By Ultrafiltration (2022-2030) ($MN)
  • Table 9 Global Microbiological Testing of Water Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 10 Global Microbiological Testing of Water Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 11 Global Microbiological Testing of Water Market Outlook, By Pathogen Type (2022-2030) ($MN)
  • Table 12 Global Microbiological Testing of Water Market Outlook, By Coliform (2022-2030) ($MN)
  • Table 13 Global Microbiological Testing of Water Market Outlook, By Vibrio (2022-2030) ($MN)
  • Table 14 Global Microbiological Testing of Water Market Outlook, By Legionella (2022-2030) ($MN)
  • Table 15 Global Microbiological Testing of Water Market Outlook, By Clostridium (2022-2030) ($MN)
  • Table 16 Global Microbiological Testing of Water Market Outlook, By Salmonella (2022-2030) ($MN)
  • Table 17 Global Microbiological Testing of Water Market Outlook, By Other Pathogen Types (2022-2030) ($MN)
  • Table 18 Global Microbiological Testing of Water Market Outlook, By Water Type (2022-2030) ($MN)
  • Table 19 Global Microbiological Testing of Water Market Outlook, By Drinking and Bottled Water (2022-2030) ($MN)
  • Table 20 Global Microbiological Testing of Water Market Outlook, By Industrial Water (2022-2030) ($MN)
  • Table 21 Global Microbiological Testing of Water Market Outlook, By End User (2022-2030) ($MN)
  • Table 22 Global Microbiological Testing of Water Market Outlook, By Food & Beverage (F&B) Industry (2022-2030) ($MN)
  • Table 23 Global Microbiological Testing of Water Market Outlook, By Pharmaceutical and Biotechnology (2022-2030) ($MN)
  • Table 24 Global Microbiological Testing of Water Market Outlook, By Hospitals and Healthcare (2022-2030) ($MN)
  • Table 25 Global Microbiological Testing of Water Market Outlook, By Industrial Process (2022-2030) ($MN)
  • Table 26 Global Microbiological Testing of Water Market Outlook, By Environmental (2022-2030) ($MN)
  • Table 27 Global Microbiological Testing of Water Market Outlook, By Chemicals and Materials (2022-2030) ($MN)
  • Table 28 Global Microbiological Testing of Water Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.